Recent Updates
Recently added Catalysts
PALI Positive Sentiment Score: 75/100

Palisade Bio Announces Abstract Accepted for Presentation at the American College of Gastroenterology’s (ACG) 2024 Annual Scientific Meeting

Tuesday, October 15, 2024 1 min read
Key Takeaway: Palisade Bio, Inc. announced that its abstract has been accepted for a poster presentation at the American College of Gastroenterology's 2024 Annual Scientific Meeting scheduled for October 25-30, 2024, in Philadelphia. The event is significant for professionals in the gastrointestinal field as it aims to educate about digestive disorders. Palisade Bio is concentrating on innovative therapeutics for patients with autoimmune, inflammatory, and fibrotic diseases, reflecting its focus on transforming treatment options.

Market Sentiment Analysis

POSITIVE FACTORS

  • The abstract acceptance for presentation showcases the relevance of Palisade Bio's work.
  • Participation in a significant meeting like ACG reflects the company's commitment to advancing therapeutic options.
  • The focus on autoimmune, inflammatory, and fibrotic diseases highlights a crucial area in healthcare.

Full Press Release Details

Carlsbad, CA, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that its abstract has been accepted for poster presentation at ACG’s 2024 Annual Scientific Meeting being held October 25-30, 2024 in Philadelphia, PA.
The American College of Gastroenterology (ACG) is a recognized leader in educating GI professionals and the general public about digestive disorders. For more information about the ACG Annual Meeting, please visit the conference website.
Palisade Bio is a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The Company believes that by using a targeted approach with its novel therapeutics it will transform the treatment landscape. For more information, please go to www.palisadebio.com.
Investor Relations Contact

Tags

biopharmaceutical company
Annual Scientific Meeting

Frequently Asked Questions

What is Palisade Bio focused on?

Palisade Bio develops innovative therapeutics for autoimmune, inflammatory, and fibrotic diseases.

When will the ACG Annual Scientific Meeting take place?

The ACG Annual Scientific Meeting is scheduled for October 25-30, 2024.

Where is the ACG Annual Meeting held?

The 2024 ACG Annual Meeting will be in Philadelphia, PA.

What will Palisade Bio present at the conference?

Palisade Bio's abstract has been accepted for poster presentation at the meeting.

What is the ACG's role in healthcare?

The ACG educates GI professionals and the public on digestive disorders.

Tags: PALI Viatris Investor Conferences Healthcare Palisade Bio ACG 2024 biopharmaceutical digestion disorders therapeutics
Last updated: Oct 15, 2024